Bay Street News, October, 2020

Study did not meet primary endpoint of reducing rate of pulmonary exacerbationsLenabasum treatment had a favorable safety profile and was […]

CALGARY, Alberta, Oct. 06, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “Flyht”) […]

BEIJING, Oct. 06, 2020 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used […]

TEL AVIV, Israel and RALEIGH, N.C., Oct. 06, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the […]

Primary axillary hyperhidrosis is estimated to affect over 10 million people in the U.S.Sofpironium bromide is a retrometabolically designed investigational […]

SAN CARLOS, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]

• AXO-Lenti-PD was well-tolerated with no treatment–related serious adverse events at 6 months• 21-point mean improvement in UPDRS Part III […]

PHILADELPHIA, Oct. 06, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative […]

BRIDGEVILLE, Pa., Oct. 06, 2020 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it […]

BURLINGAME, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO) a […]